HUE045407T2 - Hafnium(IV)-oxid vagy rénium(IV)-oxid vagy nanorészecskéket tartalmazó készítmények ionizáló sugarakkal kombinálva, rák kezelésére - Google Patents
Hafnium(IV)-oxid vagy rénium(IV)-oxid vagy nanorészecskéket tartalmazó készítmények ionizáló sugarakkal kombinálva, rák kezeléséreInfo
- Publication number
- HUE045407T2 HUE045407T2 HUE14701965A HUE14701965A HUE045407T2 HU E045407 T2 HUE045407 T2 HU E045407T2 HU E14701965 A HUE14701965 A HU E14701965A HU E14701965 A HUE14701965 A HU E14701965A HU E045407 T2 HUE045407 T2 HU E045407T2
- Authority
- HU
- Hungary
- Prior art keywords
- oxide
- rhenium
- hafnium
- nanoparticles
- compositions
- Prior art date
Links
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(iv) oxide Chemical compound O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000005865 ionizing radiation Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- WXBOMIKEWRRKBB-UHFFFAOYSA-N rhenium(iv) oxide Chemical compound O=[Re]=O WXBOMIKEWRRKBB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361756533P | 2013-01-25 | 2013-01-25 | |
| EP13305087 | 2013-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE045407T2 true HUE045407T2 (hu) | 2019-12-30 |
Family
ID=67296872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14701965A HUE045407T2 (hu) | 2013-01-25 | 2014-01-24 | Hafnium(IV)-oxid vagy rénium(IV)-oxid vagy nanorészecskéket tartalmazó készítmények ionizáló sugarakkal kombinálva, rák kezelésére |
Country Status (9)
| Country | Link |
|---|---|
| DK (1) | DK2948179T3 (hu) |
| ES (1) | ES2734493T3 (hu) |
| HR (1) | HRP20191272T1 (hu) |
| HU (1) | HUE045407T2 (hu) |
| LT (1) | LT2948179T (hu) |
| NZ (2) | NZ750194A (hu) |
| PT (1) | PT2948179T (hu) |
| SG (1) | SG10202105500VA (hu) |
| TR (1) | TR201910251T4 (hu) |
-
2014
- 2014-01-24 HU HUE14701965A patent/HUE045407T2/hu unknown
- 2014-01-24 TR TR2019/10251T patent/TR201910251T4/tr unknown
- 2014-01-24 SG SG10202105500VA patent/SG10202105500VA/en unknown
- 2014-01-24 ES ES14701965T patent/ES2734493T3/es active Active
- 2014-01-24 PT PT14701965T patent/PT2948179T/pt unknown
- 2014-01-24 HR HRP20191272TT patent/HRP20191272T1/hr unknown
- 2014-01-24 DK DK14701965.7T patent/DK2948179T3/da active
- 2014-01-24 NZ NZ750194A patent/NZ750194A/en unknown
- 2014-01-24 LT LTEP14701965.7T patent/LT2948179T/lt unknown
- 2014-01-24 NZ NZ70968514A patent/NZ709685A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ709685A (en) | 2019-10-25 |
| NZ750194A (en) | 2020-02-28 |
| ES2734493T3 (es) | 2019-12-10 |
| HRP20191272T1 (hr) | 2019-10-18 |
| TR201910251T4 (tr) | 2019-07-22 |
| LT2948179T (lt) | 2019-08-12 |
| SG10202105500VA (en) | 2021-07-29 |
| PT2948179T (pt) | 2019-07-19 |
| DK2948179T3 (da) | 2019-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2948179T1 (sl) | Sestavki, ki obsegajo nanodelce hafnij (IV) oksida ali renij (IV) oksida v kombinaciji z ionizirajočimi sevanji za zdravljenje raka | |
| IL276428A (en) | A preparation and vaccine for the treatment of lung cancer | |
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| IL245281A0 (en) | Methods and preparations for the treatment of cancer | |
| SG10201801433XA (en) | Composition and vaccine for treating prostate cancer | |
| GB2516814B (en) | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer | |
| IL239453B (en) | Preparations and methods for treating cancer using bacteria | |
| ZA201602380B (en) | Cancer treatment with combination of plinabulin and taxane | |
| IL244353A0 (en) | Compounds and use for cancer treatment | |
| IL241823B (en) | Preparations containing novyi .c and their uses for the treatment of cancerous tumors | |
| EP3052102A4 (en) | Compositions and methods for treating cancers | |
| EP3004395A4 (en) | Compositions and methods for treating cancer | |
| IL246065A0 (en) | Valiprib in combination with carboplatin for the treatment of triple negative breast cancer | |
| EP2984185A4 (en) | Methods and compositions for treating cancer | |
| PT2948179T (pt) | Composições que compreendem nanopartículas de óxido de háfnio (iv) ou óxido de rénio (iv) em combinação com radiações ionizantes para tratamento do câncro | |
| WO2014160368A9 (en) | Compositions and methods for treating cancer | |
| PL3035955T3 (pl) | Kompozycja i szczepionka do leczenia raka płuca | |
| GB201322958D0 (en) | Uses of oligouronates in cancer treatment | |
| SG10201802995SA (en) | Cancer treatment with combination of plinabulin and taxane |